Home›Research›Compare›AOD-9604 vs Ghrelin
Peptide ComparisonAOD-9604 vs Ghrelin
Both are GH / IGF Axis peptides.
AOD-9604
Advanced Obesity Drug 9604
Half-life: 30–60 minutes
197 providers listed
Ghrelin
acyl ghrelin
Half-life: ~24 min (initial), ~146 min (terminal)
3 providers listed
Ghrelin carries stronger published evidence (RCT, 5 key studies) than AOD-9604 (Animal, 1); both are research compounds.
AOD-9604
Half-life
30–60 minutes
Ghrelin
Half-life
~24 min (initial), ~146 min (terminal)
| Your goal | Better option |
|---|---|
| Stronger clinical evidence | Ghrelin |
| Oral administration option | AOD-9604 |
| More provider options (197 vs 3) | AOD-9604 |
Research summary only — not medical advice. Consult a qualified provider before making any decisions.
AOD-9604
Ghrelin
AOD-9604
Ghrelin
A Secondary, Subgroup Analysis of Alcohol Cue-Exposure Craving in Response to Pharmacological Inhibition of t…
Pilot clinical trial of macimorelin to assess safety and efficacy in patients with cancer cachexia
Safety, tolerability, pharmacokinetics, and pharmacodynamics of macimorelin in healthy adults: Results of a s…
Constant intravenous ghrelin infusion in healthy young men: clinical pharmacokinetics and metabolic effects
+1 more
About AOD-9604
AOD-9604 stimulates lipolysis and inhibits lipogenesis through mechanisms believed to be independent of the insulin-like growth factor pathway. It appears to mimic the fat-metabolising action of growth hormone without triggering the proliferative effects associated with full GH or GH-releasing peptides. Oral bioavailability has been observed in some formulations, making it of interest for non-injectable protocols.
About Ghrelin
Must be acylated at Ser3 (by GOAT enzyme) for GHSR-1a binding. Receptor activation in the pituitary stimulates GH release; hypothalamic action via NPY/AgRP neurons increases appetite and reduces energy expenditure.
Information below reflects published research data only — not medical advice. Consult a qualified provider before use.
AOD-9604
No established clinical contraindications. This is an investigational compound with limited human data and has not been evaluated by the FDA for safety in this context. Consult a qualified clinician.
Ghrelin
Under clinical review
Being verified by our medical team before we display contraindications for this peptide.
AOD-9604
Ghrelin
Not enough vendor pricing yet.
Where to source these peptides
AOD-9604
197 listed
Browse directory →
Providers offeringGhrelin
3 listed
Browse directory →
PeptideBase lists providers for educational research purposes only. Always consult a qualified healthcare professional before obtaining or using any peptide.
More GH / IGF Axis Comparisons
Browse all peptides →Educational research tools — not medical advice.
Cite this page
Data last updated August 26, 2026
Free to reference and republish with attribution to PeptideBase. Choose a format:
PeptideBase. (2026). AOD-9604 vs Ghrelin — Per-mg Price Comparison. Retrieved August 26, 2026, from https://peptidebase.io/peptides/compare/aod-9604/ghrelin